These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28506088)
1. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions. Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088 [TBL] [Abstract][Full Text] [Related]
2. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer. Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of platelet indices as a useful marker in papillary thyroid carcinoma. Dincel O; Bayraktar C Bratisl Lek Listy; 2017; 118(3):153-155. PubMed ID: 28319410 [TBL] [Abstract][Full Text] [Related]
4. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter. Hou X; Jiang L; Chen C; Zhu X; Ge M Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079 [TBL] [Abstract][Full Text] [Related]
5. A comparison of haemogram parameters of patients with thyroid papillary cancer and nodular goiter in Van, Turkey. Yildiz S; Eker E; Ozturk M; Alay M J Pak Med Assoc; 2019 Nov; 69(11):1642-1646. PubMed ID: 31740871 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140 [TBL] [Abstract][Full Text] [Related]
7. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size. Cheong TY; Hong SD; Jung KW; So YK PLoS One; 2021; 16(5):e0251446. PubMed ID: 33974674 [TBL] [Abstract][Full Text] [Related]
9. [Thyroid masses: an analysis of 131 cases]. Cağli S; Yüce I; Bayram A; Güney E Kulak Burun Bogaz Ihtis Derg; 2008; 18(5):289-93. PubMed ID: 19155674 [TBL] [Abstract][Full Text] [Related]
10. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma. Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240 [TBL] [Abstract][Full Text] [Related]
11. Correlation of thyroid fine-needle aspiration with final histopathology: a case series. Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of well-differentiated thyroid cancer associated with multinodular goiter. Cheng SP; Liu CL; Tzen CY; Yang TL; Jeng KS; Liu TP; Lee JJ Langenbecks Arch Surg; 2008 Sep; 393(5):729-32. PubMed ID: 18404277 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions]. Tong J; Wang Y; Da JP Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220 [TBL] [Abstract][Full Text] [Related]
15. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter. Evren B; Yılmaz S; Karadağ N; Sertkaya AÇ; Topaloğlu Ö; Kılınç F Sci Rep; 2021 May; 11(1):9932. PubMed ID: 33976347 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma]. Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201 [No Abstract] [Full Text] [Related]
18. Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas. Baldane S; Ipekci SH; Sozen M; Kebapcilar L Asian Pac J Cancer Prev; 2015; 16(7):2671-4. PubMed ID: 25854344 [TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma. Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746 [TBL] [Abstract][Full Text] [Related]
20. [Morphometric analysis of the degree of thyrocyte aggregation in the preoperative diagnosis of thyroid cancer]. Kirillov VA; Iushchenko IuP Klin Lab Diagn; 1996; (4):13-6. PubMed ID: 8963549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]